Jeff Garro
Stock Analyst at Stephens & Co.
(1.87)
# 3,236
Out of 5,012 analysts
54
Total ratings
40.54%
Success rate
-9.33%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $24.02 | +33.22% | 5 | Sep 24, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $8.12 | +10.84% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $23.41 | +36.69% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $16.50 | +21.21% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.06 | +39.58% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $306.22 | -8.56% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.85 | +75.44% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $12.93 | +31.48% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.19 | +56.74% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $71.38 | -22.95% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $5.5 | $17.95 | -69.36% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $200.86 | +24.46% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.66 | -13.53% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.37 | +234.53% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.98 | +17.79% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.21 | -25.14% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.96 | +53.06% | 3 | May 6, 2022 |
Privia Health Group
Sep 24, 2025
Reiterates: Overweight
Price Target: $32
Current: $24.02
Upside: +33.22%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $8.12
Upside: +10.84%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.41
Upside: +36.69%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $16.50
Upside: +21.21%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.06
Upside: +39.58%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $306.22
Upside: -8.56%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.85
Upside: +75.44%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $12.93
Upside: +31.48%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.19
Upside: +56.74%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $71.38
Upside: -22.95%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $17.95
Upside: -69.36%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $200.86
Upside: +24.46%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.66
Upside: -13.53%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.37
Upside: +234.53%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $16.98
Upside: +17.79%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.21
Upside: -25.14%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.96
Upside: +53.06%